Introducing Medisca Nutraceuticals

Download in electronic PDF format for $25



Search the Complete Journal Archives

Stability of an Extemporaneously Compounded Propylthiouracil Suspension

Author(s):  Alexander Kenneth S, Mitra Pallabi

Issue:  Jan/Feb 2005 - Sterile Preparations
View All Articles in Issue

Abstract:  The stability of the antithyroid drug propylthiouracil was studied in an extemporaneously formulated suspension for 91 days. A simple, rapid, reproducible, and stability-indicating reverse-phase high-performance liquid chromatographic assay method was developed for detecting propylthiouracil. The mobile phase consisted of a 70:30 (v/v) combination of water and methanol at a flow rate of 0.5 mL/minute. The detector wavelength was set at 276 nm. Excellent linearity (R2 value 0.9929) was obtained over the working solution range (1 to 100 mcg/mL). The intraday and interday precisions of the assay method were 0.11% to 1.28% and 1.65%, respectively. The drug was subjected to forced degradation under acidic and basic condtiions, and the method proved to be stability indicating for propylthiouracil. A suspension was formulated using commercially available 50-mg propylthiouracil tablets. The formulation consisted of a combination of 0.75% carboxymethylcellulose sodium and 0.5% Veegum as the suspending agents; 25% (w/v) simple syrup, 25% (w/v) sorbitol solution, and 0.15% saccharin as the sweeteners; paraben concentrate as the preservative, and a mixture of wild cherry, raspberry, and tangerine as the flavor. The suspension was stored at 4, 30, 50, 60, and 70 degrees C and analyzed on a weekly basis for 91 days. The samples were assayed in triplicate by the high-performance liquid chromatographic assay method outlined. The apparent zero-order rate constant for degradation of propylthiouracil at each of the temperatures was obtained and used to obtain the Arrhenius plot. From the regression line of the Arrhenius plot, the rate constant for degradation (t0.9) at room temperature (25 degrees C) and under refrigeration (4 degrees C) was found to be 0.078%day-1 and 0.04%day-1. The shelf life of the suspension was calculated to be 127 days at room temperature and 248 days under refrigeration.

Related Keywords: Kenneth S. Alexander, PhD, Pallabi Mitro, hyperthyroidism, stability, thionamides, children, assay development, PTU, elderly

Related Categories: EXCIPIENTS, GERIATRICS, PEDIATRICS, PEER-REVIEWED, STABILITIES, COMPATIBILITIES, ENDOCRINOLOGY/HORMONES/ MENOPAUSE/ANDROPAUSE

Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Stability of an Extemporaneously Compounded Propylthiouracil Suspension Alexander Kenneth S, Mitra Pallabi Jan/Feb 2005 82-86 Buy
Pain Management in the Elderly Peralta Alexander Jr May/Jun 2004 187 Buy
Formulation Development and Stability Testing of Extemporaneous Suspension Prepared From Dapsone Tablets Kaila Nitin, El-Ries Mohamed, Riga A, Alexander Kenneth S, Dollimore D May/Jun 2003 233-239 Buy
Development of Extemporaneously Compounded Aripiprazole Oral Suspensions for Use in Children Pramann Lance A, Davidow Lawrence W, van Haandel Leon, Funk Ryan S May/Jun 2016 257-261 Buy
Extemporaneous Formulation and Stability Testing of Mexiletine HCl Solution Alexander Kenneth S, Kaushik Sarita Mar/Apr 2004 147-152 Buy
Transdermal Methimazole in the Treatment of 16 Cats with Hyperthyroidism Wingate Gary Sep/Oct 2002 344 Buy
The Formulation Development and Stability of Spironolactone Suspension Alexander Kenneth S, Vangala Shyam Sundar KS, White Donald B, Dollimore David May/Jun 1997 195-199 Buy
The Formulation Development and Stability of Metronidazole Suspension Alexander Kenneth S, Vangala Shyam Sundar KS, Dollimore David May/Jun 1997 200-205 Buy
Preparation and In Vitro Evaluation of a Pluronic Lecithin Organogel Containing Ricinoleic Acid for Transdermal Delivery Boddu Sai HS, Bonam Sindhu Prabha, Wei Yangjie, Alexander Kenneth May/Jun 2014 256-261 Buy
Comparing Suppository Mold Variability Which Can Lead to Dosage Errors for Suppositories Prepared with the Same or Different Molds Alexander Kenneth S, Baki Gabriella, Hart Christine, Hejduk Courtney, Chillas Stephanie Nov/Dec 2013 512-514 Buy